Recent discussions on X about Procter & Gamble (PG) have been buzzing with reactions to the company’s stock performance and insider activity. Many users are focusing on the recent decline in share price, which dropped to $150.41 as noted in web updates, sparking debates about potential buying opportunities. The upcoming 2025 Virtual Annual Meeting of Shareholders has also drawn attention as a key event to watch for strategic updates.
Additionally, posts on X have highlighted multiple insider sales over the past few days, raising eyebrows among investors about the timing and implications of these transactions. Some are questioning whether this signals a lack of confidence from within, while others argue it could be routine portfolio management. The mixed reactions keep the conversation dynamic as the consumer goods giant navigates a sideways market.
Note: This discussion summary was generated from an AI condensation of post data.
Procter & Gamble Congressional Stock Trading
Members of Congress have traded $PG stock 17 times in the past 6 months. Of those trades, 7 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 4 purchases worth up to $60,000 on 09/22, 08/13, 08/07 and 0 sales.
- REPRESENTATIVE KATHERINE M. CLARK has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/17.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE ADAM SMITH sold up to $15,000 on 08/08.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 07/02.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE CLIFF BENTZ purchased up to $15,000 on 06/06.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Procter & Gamble Insider Trading Activity
Procter & Gamble insiders have traded $PG stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:
- JON R MOELLER (Chairman, President and CEO) has made 0 purchases and 2 sales selling 51,803 shares for an estimated $8,088,342.
- SHAILESH JEJURIKAR (Chief Operating Officer) has made 0 purchases and 2 sales selling 17,025 shares for an estimated $2,657,488.
- ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 2 sales selling 15,890 shares for an estimated $2,477,641.
- R. ALEXANDRA KEITH (CEO - Beauty) has made 0 purchases and 4 sales selling 13,717 shares for an estimated $2,156,107.
- GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 13,729 shares for an estimated $2,150,411.
- JENNIFER L. DAVIS (CEO - Health Care) has made 0 purchases and 3 sales selling 12,823 shares for an estimated $2,004,561.
- MOSES VICTOR JAVIER AGUILAR (Chf Rsch, Dev & Innov Officer) sold 10,520 shares for an estimated $1,669,199
- MARC S. PRITCHARD (Chief Brand Officer) sold 9,849 shares for an estimated $1,548,989
- SUNDAR G. RAMAN (CEO-Fabric & Home Care) sold 9,554 shares for an estimated $1,511,050
- SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 3 sales selling 9,575 shares for an estimated $1,493,316.
- MA. FATIMA FRANCISCO (CEO - Baby, Fem & Family Care) sold 9,100 shares for an estimated $1,431,191
- BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 1,096 shares for an estimated $169,901.
- MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) sold 319 shares for an estimated $50,170
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Procter & Gamble Hedge Fund Activity
We have seen 1,664 institutional investors add shares of Procter & Gamble stock to their portfolio, and 1,911 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 76,017,350 shares (+655209.0%) to their portfolio in Q2 2025, for an estimated $12,111,084,202
- WELLINGTON MANAGEMENT GROUP LLP removed 8,424,738 shares (-37.8%) from their portfolio in Q2 2025, for an estimated $1,342,229,258
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 7,588,470 shares (-76.9%) from their portfolio in Q2 2025, for an estimated $1,208,995,040
- BLACKROCK, INC. removed 6,074,841 shares (-3.4%) from their portfolio in Q2 2025, for an estimated $967,843,668
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,527,584 shares (+25.7%) to their portfolio in Q2 2025, for an estimated $880,654,682
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,241,351 shares (+30.3%) to their portfolio in Q2 2025, for an estimated $835,052,041
- VANGUARD GROUP INC added 3,189,111 shares (+1.4%) to their portfolio in Q2 2025, for an estimated $508,089,164
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Procter & Gamble Analyst Ratings
Wall Street analysts have issued reports on $PG in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 09/25/2025
- UBS issued a "Buy" rating on 07/17/2025
- B of A Securities issued a "Buy" rating on 04/25/2025
- Morgan Stanley issued a "Overweight" rating on 04/25/2025
- Raymond James issued a "Outperform" rating on 04/25/2025
- Truist Securities issued a "Buy" rating on 04/25/2025
- RBC Capital issued a "Outperform" rating on 04/25/2025
To track analyst ratings and price targets for Procter & Gamble, check out Quiver Quantitative's $PG forecast page.
Procter & Gamble Price Targets
Multiple analysts have issued price targets for $PG recently. We have seen 13 analysts offer price targets for $PG in the last 6 months, with a median target of $177.0.
Here are some recent targets:
- Lauren Lieberman from Barclays set a target price of $153.0 on 10/01/2025
- Chris Carey from Wells Fargo set a target price of $170.0 on 09/25/2025
- Kevin Grundy from BNP Paribas set a target price of $177.0 on 08/15/2025
- Andrea Teixeira from JP Morgan set a target price of $170.0 on 07/25/2025
- Peter Grom from UBS set a target price of $180.0 on 07/17/2025
- Robert Ottenstein from Evercore ISI Group set a target price of $170.0 on 07/14/2025
- Korinne Wolfmeyer from Piper Sandler set a target price of $164.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
